ICU Medical, Inc. Announces Fourth Quarter 2018 Results

Go back to ICU Medical, Inc. Announces Fourth Quarter 2018 Results

ICU Medical (ICUI) PT Lowered to $300 at Raymond James

March 1, 2019 7:33 AM EST

Raymond James analyst Jayson Bedford lowered the price target on ICU Medical (NASDAQ: ICUI) to $300.00 (from $315.00) while maintaining a Strong Buy rating.

Bedford said while Q4 was nicely above the mix was different than their thinking. The firm trimmed revenue estimates to... More

ICU Medical (ICUI) Tops Q4 EPS by 27c, Revenues Beat; Offers FY19 EPS Mid-Point Guidance Above Consensus

February 28, 2019 4:46 PM EST

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $2.07, $0.27 better than the analyst estimate of $1.80. Revenue for the quarter came in at $340.4 million versus the consensus estimate of $315.77 million.

Fourth quarter 2018 revenue was $340.4 million, compared to $370.1 million in the same period last... More